I find the paper frustratingly light on details, skimming over lots of issues. I think there could have been a few good papers in the DecodeME questionnaire results- maybe there still could be. Less is usually more in terms of the scope of papers, I reckon.
50.6% (
n= 8,637) of participants (all with self-reported ME/CFS diagnosed by a health professional) reported two or more comorbid conditions, most commonly irritable bowel syndrome (IBS; 41.3%;
n=7,052), clinical depression (32.4%;
n=5,537) and fibromyalgia (29.5%;
n=5,043), anaemia (14.1%;
n=2,402) and hypothyroidism (12.8%;
n=2,178) (
Figure 2).
True, but women are also much more likely to be diagnosed with autoimmune diseases, endometriosis and adenomyosis.
Yes. Possibly those conditions actually explain the symptoms being attributed to ME/CFS and some of the women don't have ME/CFS.
The paper tells us that 34 conditions were considered as co-morbidities. But Figure 7 only tells us about five:
Thirty-four comorbidities were considered in a logistic regression model of the form OnsetType ~ age + sex + comorbidities and an intercept. A covariate is only shown if it survived Bonferroni multiple testing correction ( p<0.05) for one or more onset type. Active and inactive comorbidities were considered independently: Active, if the condition has given symptoms in the past 6 months, or Inactive, if the condition has not given symptoms in the past 6 months, either because it has died down or treatment has controlled it. The z-score (Y-axis) is the effect-size estimate in standard deviation units.
They were MCAS active, Lyme disease active, clinical depression active, fibromyalgia active, and shingles not active. ('Active' being the disease was reported as causing symptoms in the last 6 months.)
The four active 'co-morbidities' could easily just be diagnostic constructs. By that I mean that they aren't really reflecting a unique additional pathology but are actually just ideas that a doctor has made up and convinced the person about.
For example, MCAS. That is reported as being associated with a Covid-19 onset. I suspect many of the doctors that would diagnose a person presenting with post-covid-19 symptoms as having ME/CFS also diagnose the person with MCAS at the same time. Whereas, a person presenting with ME/CFS symptoms 10 or more years ago probably would not have got that extra MCAS diagnosis.
A diagnosis of Lyme disease was associated with an ME/CFS onset caused by an infection other than Covid-19 and EBV. A diagnosis of clinical depression and the person reporting it as 'active' was associated with the ME/CFS onset being reported as not caused by an infection trigger. That makes sense as the person's diagnostic odyssey was probably longer and more difficult. Their doctors were probably more likely to suggest that their disease was depression than if the person's illness had clearly started with, for example, glandular fever.
My point is, being diagnosed with these co-morbidities doesn't necessarily line up well with having more severe ME/CFS. The diagnoses are a reflection of the beliefs of the doctors the people have seen. And, given the questionnaire seemed to ask the participants to endorse the co-morbidity diagnoses by only calling them 'active' if the person attributed symptoms to them in the last six months, they also reflect the willingness of the person to accept the diagnoses as true.